Back to discover
Drug

Trifluoperazine

In clinical development
Emerging researchEarly-to-mid development
Also known as Stelazine, trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine, Trifluoperazina, Trifluopérazine+4 more

Stelazine, trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine, Trifluoperazina, Trifluopérazine, Trifluoroperazine, Trifluperazine, Trifluoperazine Hydrochloride, Trifluoperazinum.

RxNorm10800ChEMBLCHEMBL422ATCN05AB06UNII214IZI85K3
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Trifluoperazine
Aliases & brands
Stelazinetrifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazineTrifluoperazinaTrifluopérazineTrifluoroperazineTrifluperazineTrifluoperazine HydrochlorideTrifluoperazinum
RxNorm CUI
10800
ChEMBL ID
CHEMBL422
ATC codes
N05AB06
UNII
214IZI85K3

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
1
Discontinued
PHASE DISTRIBUTIONn = 1
Phase 1 / 21

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Journals, researchers & institutions
Top journals
  • Cell1
Leading researchers
  • Ahmed Z1
  • Al-Jubair T1
  • Almutiri S1
  • Bill RM1
  • Clarke-Bland C1
  • Conner AC1
  • Conner MT1
  • Gourdon P1
Leading institutions
free-text, unnormalised
  • Cumming School of Medicine1
  • Harvard Medical School1
  • Institute of Clinical Sciences1
  • Institute of Inflammation and Ageing1
  • Lund University1
  • School of Life & Health Sciences1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials